SEARCH

SEARCH BY CITATION

References

  • Asami-Odaka A., Ishibashi Y., Kikuchi T., Kitada C. and Suzuki N. (1995) Long amyloid beta-protein secreted from wild-type human neuroblastoma IMR-32 cells. Biochemistry 32, 1027210278.
  • Barlow-Walden L. R., Reiter R. J., Pablos M., Menedez-Peleaz A., Chen L.-D. and Poeggeler B. (1995) Melatonin stimulates glutathione peroxidase. Neurochem. Int. 26, 497502.
  • Bozner P., Grishko V., LeDoux S. P., Wilson G. L., Chyan Y.-J. and Pappolla M. A. (1997) The amyloid β protein induces oxidative damage of mitochondrial DNA. J. Neuropath. Exp. Neurol. 56, 13561362.
  • Cagnoli C. M., Atabay C., Kharlamova E. and Manev H. (1995) Melatonin protects neurons from singlet oxygen-induced apoptosis. J. Pineal Res. 18, 222226.
  • Chyan Y.-J., Poeggeler B., Omar R. A., Chain D. G., Frangione B., Ghiso J. and Pappolla M. A. (1999) Potent neuroprotective properties against the Alzheimer beta-amyloid by an endogenous melatonin-related indole structure, indole-3-propionic acid. J. Biol. Chem. 274, 2193721942.
  • Cuzzocrea S., Zingarelli B., Costantino G. and Caputi A. P. (1998) Protective effect of melatonin in a non-septic shock model induced by zymosan in the rat. J. Pineal Res. 25, 2433.
  • Esiri M. M., Hyman B., Beyreuther K. and Masters C. L. (1997) Greenfield's Neuropathology (GrahamD. I. and LantioP. L., eds), pp. 151233. Arnold Publishers, London.
  • Gilad E., Cuzzocrea S., Zingarelli B., Salzman A. L. and Szabo C. (1997) Melatonin is a scavenger of peroxynitrite. Life Sci. 60, PL169174.
  • Glenner G. G. and Wong C. W. (1984) Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein. Biochem. Biophys. Res. Commun. 120, 885890.
  • Good P. F., Werner P., Hsu A., Olanow C. W. and Perl D. P. (1996) Evidence of neuronal oxidative damage in Alzheimer's disease. Am. J. Pathol. 149, 2128.
  • Hendler S. S. and Rorvik D., eds. (2001)PDR for Nutritional Supplements, pp. 302306. Medical Economics Company, Inc., Montvale, NJ.
  • Hsiao K. K., Borchelt D. R., Olson K., Johannsdottir R., Kitt C., Yunis W., Xu S., Eckman C., Younkin S. and Price D. (1995) Age-related CNS disorder and early death in transgenic FVB/N mice overexpressing Alzheimer amyloid precursor proteins. Neuron 15, 12031218.
  • Hsiao K., Chapman P., Nilsen S., Eckman C., Harigaya Y., Younkin S., Yang F. and Cole G. (1996) Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice. Science 274, 99102.
  • Iguchi H., Kato K. and Ibayashi H. (1982) Melatonin serum levels and metabolic clearance rate in patients with liver cirrhosis. J. Clin. Endocrinol. Metab. 54, 10251027.
  • Johnson-Wood K., Lee M., Motter R., Hu K., Gordon G., Barbour R., Khan K., Gordon M., Tan H., Games D., Lieberburg I., Schenk D., Seubert P. and McConlogue L. (1997) Amyloid precursor protein processing and Abeta42 deposition in a transgenic mouse model of Alzheimer disease. Proc. Natl Acad. Sci. USA 94, 15501555.
  • Kilic E., Ozdemir Y. G., Bolay H., Kelestimur H. and Dalkara T. (1999) Pinealectomy aggravates and melatonin administration attenuates brain damage in focal ischemia. J. Cerebral Blood Flow Metab. 19, 511516.
  • King M. and Scaiano J. C. (1997) The excited states of melatonin. Photochem. Photobiol. 65, 538542.
  • Liu R.-Y., Zhou J.-N., Van Heerikhuize J., Hofman M. A. and Swaab D. F. (1999) Decreased melatonin levels in postmortem cerebrospinal fluid in relation to aging, Alzheimer's disease and apolipoprotein E-ε4/4 genotype. J. Clin. Endocrinol. Metab. 84, 323327.
  • Manev H., Uz T., Kharlamov A., Cognali C. M., Franseschini P. and Giusti P. (1996) In vivo protection against kainate-induced apoptosis by pineal hormone melatonin: effect of exogenous melatonin and circadian rhythm. Restor. Neurol. Neurosci. 9, 251256.
  • Masters C. L., Simms G., Weinman N. A., Multhaup G., McDonald B. L., and Beyreuther K. (1985) Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc. Natl Acad. Sci. USA 82, 42454294.
  • Matsubara E., Ghiso J., Frangione B., Amari M., Tomidokoro Y., Lkeda Y., Harigaya Y., Okamoto K. and Shoji M. (1999) Lipoprotein-free amyloidogenic peptides in plasma are elevated in patients with sporadic Alzheimer's disease and Down's syndrome. Ann. Neurol. 45, 537541.
  • Mishima K., Okawa M., Hishikawa Y., Hozumi S., Hori H. and Takahashi K. (1994) Morning bright light therapy for sleep and behavior disorders in elderly patients with dementia. Acta Psychiat. Scand. 89, 17.
  • Müller-Wieland D., Behnke B., Koopmann K. and Krone W. (1994) Melatonin inhibits LDL receptor activity and cholesterol synthesis in freshly isolated human mononuclear leukocytes. Biochem. Biophys. Res. Commun. 203, 416421.
  • Naslund J., Haroutunian V., Mohs R., Davis K. L., Davies P., Greengard P. and Buxbaum J. D. (2000) Correlation between elevated levels of amyloid β-peptide in the brain and cognitive decline. JAMA 283, 16151617.
  • Neve R. L. and Robakis N. K. (1998) Alzheimer's disease: a re-examination of the amyloid hypothesis. Trends Neurosci. 21, 1519.
  • Nunomura A., Perry G., Aliev G., Hirai K., Takeda A., Balraj E. K., Jones P. K., Ghanbari H., Wataya T., Shimohama S., Chiba S., Atwood C. S., Petersen R. B. and Smith M. A. (2001) Oxidative damage is the earliest event in Alzheimer disease. J. Neuropathol. Exp. Neurol. 60, 759767.
  • Pang S. F., Ralph C. L. and Reilley P. (1974) Melatonin in the chicken brain: its origin, diurnal variation and regional distribution. General Comp Endocrinal. 22, 499506.
  • Pappolla M. A., Sos M., Omar R. A., Bick R. J., Hickson-Bick D. L. M., Reiter R. J., Efthimiopoulos S. and Robakis N. K. (1997) Melatonin prevents death of neuroblastoma cells exposed to the Alzheimer's amyloid peptide. J. Neurosci. 17, 16831690.
  • Pappolla M. A., Bozner P., Soto C., Shao H., Robakis N. K., Zagorski M., Frangione B. and Ghiso J. (1998) Inhibition of Alzheimer β-fibrillogenesis by melatonin. J. Biol. Chem. 273, 71857189.
  • Pappolla M. A., Chyan Y.-J., Poeggeler B., Frangione B., Wilson G., Ghiso J. and Reiter R. J. (2000) An assessment of the antioxidant and antiamyloidogenic properties of melatonin: implications for Alzheimer's disease. J. Neural Transm. 107, 203231.
  • Poeggeler B. and Hardeland R. (1994) Detection and quantification of melatonin in a dinoflagellate, Gonyaulax polyedra. Solutions to the problem of methoxyindole destruction in non-vertebrate material. J. Pineal Res. 17, 110.
  • Poeggeler B., Saarela S., Reiter R. J., Tan D. X., Chen L. D., Manchester L. C. and Barlow-Walden L. R. (1994) Melatonin – a highly potent endogenous radical scavenger and electron donor: new aspects of the oxidation chemistry of this indole assessed in vitro. Ann. NY Acad. Sci. 738, 419420.
  • Poeggeler B., Miravalle L., Zagorski M. G., Wisniewski T., Chyan Y.-J., Zhang Y., Shao H., Bryant-Thomas T., Vidal R., Frangione B., Ghiso J. and Pappolla M. A. (2001) Melatonin reverses the profibrillogenic activity of apolipoprotein E4 on the Alzheimer amyloid Aβ peptide. Biochemistry 40, 1499515001.
  • Pratico D., Uryu K., Leight S., Trojanoswki J. Q. and Lee V. M. (2001) Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis. J. Neurosci. 21, 41834187.
  • Refolo L. M., Malester B., LaFrancios J., Bryant-Thomas T., Wang R., Tint S., Sambamurti K., Duff K. and Pappolla M. A. (2000) Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model. Neurobiol. Dis. 7, 321331.
  • Reiter R. J. (1992) The aging pineal gland and its physiological consequences. Bioessays 14, 169175.
  • Reiter R. J., Tan D. X., Acuña-Castroviejo D., Burkhardt S. and Karbownik M. (2000) Melatonin: mechanisms and actions as an antioxidant. Curr. Topics Biophys. 24, 171183.
  • Sack R. L., Lewy A. J., Erb D. L., Vollmer W. M. and Singer C. M. (1986) Human melatonin production decreases with age. J. Pineal Res. 3, 379388.
  • Sambamurti K., Sevlever D., Koothan T., Refolo L. M., Pinnix I., Gandhi S., Onstead L., Younkin L., Prada C. M., Yager D., Ohyagi Y., Eckman C. B., Rosenberry T. L. and Younkin S. G. (1999) Glycosylphosphatidylinositol-anchored proteins play an important role in the biogenesis of the Alzheimer's amyloid beta-protein. J. Biol. Chem. 274, 2681026814.
  • Selkoe D. J. (1998) The cell biology of beta-amyloid precursor protein and presenilin in Alzheimer's disease. Trends Cell Biol. 8, 447453.
  • Smith M. A., Richey Harris P. L., Sayre L. M., Beckman J. S. and Perry G. (1997) Widespread peroxynitrite-mediated damage in Alzheimer's disease. J. Neurosci. 17, 26532657.
  • Souetre E., Salvati E., Krebs B., Belugou J. L. and Darcourt G. (1989) Abnormal melatonin response to 5-methoxypsoralen in dementia. Am. J. Psychiatry 146, 10371040.
  • Strand O. A., Leone A., Giercksky K. E. and Kirkeboen K. A. (2000) Nitric oxide indices in human septic shock. Crit. Care Med. 28, 27792785.
  • Suzuki N., Cheung T. T., Cai X. D., Odaka A., Otvos L. Jr, Eckman C., Golde T. E. and Younkin S. G. (1994) An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants. Science 264, 13361340.
  • Tan D. X., Chen L. D., Poeggeler B., Manchester L. C. and Reiter R. J. (1993) Melatonin: a potent endogenous hydroxyl radical scavenger. Endocrine J. 1, 5760.
  • Touitou Y., Fevre A. and Bogdan A. (1984) Patterns of plasma melatonin with aging and mental condition: stability of nyctoemeral rhythms and differences in season variation. Acta Endocrinol. 106, 145151.
  • Ursing C., Hartter S., Von Bahr C., Tybring G., Bertilsson L. and Rojdmark S. (2002) Does hepatic metabolism of melatonin affect the endogenous serum melatonin level in man? J. Endocrinol. Invest. 25, 459462.
  • Wolfson C., Wolfson D. B., Asgharian M., M'Lan C. E., Ostbye T., Rockwood K. and Hogan D. B. (2001) A reevaluation of the duration of survival after the onset of dementia. N. Engl. J. Med. 344, 11111116.
  • Yan S. D., Chen X., Fu J., Chen M., Zhu H., Roher A., Slattery T., Zhao L., Nagashima M., Morser J., Migheli A., Nawroth P., Stern D. and Schmidt A. M. (1996) RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease. Nature 382, 685691.
  • Zang L. Y., Cosma G., Gardner H. and Vallyathan V. (1998) Scavenging of reactive oxygen species by melatonin. Biochem. Biophys. Acta 1425, 469477.
  • Zhang L., Zhao B., Yew D. T., Kusiak J. W. and Roth G. S. (1997) Processing of Alzheimer's amyloid precursor protein during H2O2-induced apoptosis in human neuronal cells. Biochem. Biophys. Res. Commun. 235, 845848.